Phase III randomized controlled trial of gefitinib versus chemotherapy in EGFR-positive treatment-naïve metastatic lung cancer: Long-term outcome after eight years
暂无分享,去创建一个
S. Goud | S. More | Ajay Singh | Kunal Jobanputra | Minit Shah | Srushti Jain | Vijay Patil | Nandini Menon | Darshit Shah | Ahmad Ubharay | Minit J. Shah